Hrt Financial »

Zenas Biopharma shares owned by Hrt Financial

Quarter-by-quarter ownership of Zenas Biopharma shares owned by Hrt Financial from 13F filings

Historical chart of Hrt Financial investment in Zenas Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Zenas Biopharma held by Hrt Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Zenas Biopharma by Hrt Financial

Quarter filed Position value Share count Share price at filing
2024-09-30 $261k 16k 16.88

More positions owned by Hrt Financial

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Call
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Put
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Call
PG&E Corporation (PCG)
Metropcs Communications (TMUS)
Alphabet Cap Stk Cl A (GOOGL)
Verizon Communications (VZ)

View all positions for Hrt Financial

Top funds holding Zenas Biopharma

NEA Management Company
Fairmount Funds Management
NVP Associates
Deerfield Management Company
Federated Investors
Novo A/S
Perceptive Advisors
Pivotal bioVenture Partners Investment Advisor
T. Rowe Price Associates
Arrowpoint Asset Management
Monashee Investment Management
Citadel Advisors
Standard Life Aberdeen
Point72 Asset Management
Soros Fund Management

View all funds holding Zenas Biopharma